Results 91 to 100 of about 13,185 (147)

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. [PDF]

Front Mol Neurosci
Jannah AR, Hasegawa M, Ham J, Hara N, Tsukie T, Obinata A, Kikuchi M, Kasuga K, Yamaguchi H, Hamasaki H, Tada M, Kakita A, Matsumoto M, Miyashita A, Ikeuchi T.   +14 more
europepmc   +1 more source

Using iPSC models to examine neuron-glia interactions in neurodegenerative diseases. [PDF]

Biosci Rep
Lopez DM, Keavey LK, Bowles KR.
europepmc   +1 more source

Extracellular Vesicles in Tauopathies: Mechanisms and Applications. [PDF]

Int J Mol Sci
Nannuri V, Ababneh E, El Rayes S, Smith J, Sugaya K, Zhao J.   +5 more
europepmc   +1 more source

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP. [PDF]

Acta Neuropathol
Kac PR, Cousins KAQ, Szadziewska A, Shaw LM, Turton M, Van Deerlin VM, Harrison P, Zetterberg H, Wolk DA, McMillan CT, Galasko D, Hanrieder J, Lee EB, Kvartsberg H, Irwin DJ, Blennow K.   +15 more
europepmc   +1 more source

Unifying Divergent Conceptions in Nonfluent/Agrammatic and Semantic Primary Progressive Aphasia. [PDF]

Brain Sci
Teichmann M, Nakamura K.
europepmc   +1 more source

Classification of tauopathies from human brain homogenates through salt-modulated tau amplification. [PDF]

Alzheimers Dement
Santambrogio A, Metrick MA, Xu P, Gallagher NCT, Koga S, Ghetti B, Dickson DW, Caughey B, Vendruscolo M.   +8 more
europepmc   +1 more source

A critical appraisal of the link between apolipoprotein E and Tau. [PDF]

Curr Opin Neurol
Das S, Hyman BT, Serrano-Pozo A.
europepmc   +1 more source

Subtracting First Principal Component May Improve 4R Tau Detectability on [¹⁸F]Flortaucipir Tau PET. [PDF]

J Nucl Med
Satoh R, Ali F, Dickson DW, Lowe VJ, Josephs KA, Whitwell JL.   +5 more
europepmc   +1 more source

Spilling the T: T cells in tauopathy mechanisms, disease progression, and therapeutic horizons. [PDF]

Mol Neurodegener Adv
Bosch ME, Ulrich JD.
europepmc   +1 more source

Reduced plasma TIA-1: bridging established pathology and novel biomarker potential. [PDF]

Alzheimers Res Ther
Younas N, Younas A, Hermann P, Flores LCF, Dittmar K, Zafar S, Budde H, Legler TJ, Saleem T, Schmitz M, Zerr I.   +10 more
europepmc   +1 more source